Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

115.21
Delayed Data
As of 11:43am ET
 +2.08 / +1.84%
Today’s Change
71.63
Today|||52-Week Range
131.84
+6.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues31.4M49.0M64.5M71.9M
 
 
 
 
 
Cost of Goods Sold874.0K3.1M6.5M3.2M
 
 
 
 
 
Depreciation And Amortization2.7M2.7M2.7M2.6M
 
 
 
 
 
 
Operating ExpensesGross Income27.8M43.2M55.4M66.1M
 
 
 
 
 
General Expenses26.9M27.3M34.7M37.8M
 
 
 
 
 
Research And Development10.8M9.3M12.1M13.4M
 
 
 
 
 
Total Operating Expenses30.5M33.0M43.8M43.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income889.0K16.0M20.7M28.3M
 
 
 
 
 
Extraordinary Credit0.000.00544.0K27.2M
 
 
 
Extraordinary Charge-2.0M-4.6M-6.8M-5.0M
 
 
 
 
 
Pre-Tax Equity Earnings0.00-----5.1M
 
 
Interest Expense On Debt3.3M2.1M4.9M11.8M
 
 
 
 
 
Other Expenses516.0K-63.0K1.7M1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.9M9.2M11.3M35.3M
 
 
 
 
 
Income Taxes-1.2M-374.0K-410.0K-219.6M
 
 
 
 
 
Minority Interest0.000.00-1.1M-2.4M
 
 
 
Extraordinary Items2.1M2.6M0.000.00
 
 
 
Net Income-2.7M8.8M12.0M257.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.9M20.3M20.4M19.8M
 
 
 
 
 
Shares To Calculate EPS Diluted19.9M20.7M21.4M21.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03$0.55$0.56$12.12
 
 
 
 
 
EPS Diluted-$0.13$0.43$0.56$12.12